|
thapsigargin
|
BAO_0001030 |
|
|
EC 4.2.* (C-O lyase) inhibitor
|
CHEBI_76712 |
|
|
network analysis
|
BAO_0002361 |
|
|
pathway analysis by method
|
BAO_0002353 |
|
|
HeLa-MAGI-CCR5
|
CLO_0037219 |
|
|
EC 4.1.* (C-C lyase) inhibitor
|
CHEBI_76711 |
|
|
gut motility assay
|
BAO_0013030 |
|
|
Cytoscape network analysis
|
BAO_0002362 |
|
|
HL2/3
|
CLO_0037218 |
|
|
EC 4.4.* (C-S lyase) inhibitor
|
CHEBI_76714 |
|
|
target family knowledge analysis
|
BAO_0002363 |
|
|
systems biology method
|
BAO_0002347 |
|
|
EC 4.3.* (C-N lyase) inhibitor
|
CHEBI_76713 |
|
|
virtual screening
|
BAO_0002364 |
|
|
computational method
|
BAO_0002094 |
|
|
EC 4.6.* (P-O lyase) inhibitor
|
CHEBI_76716 |
|
|
EC 4.5.* (C-halide lyase) inhibitor
|
CHEBI_76715 |
|
|
obsolete bright
|
PATO_0000325 |
|
|
intensity
|
PATO_0000049 |
|
|
RS-11846 cell
|
CLO_0037214 |
|
